Investigator Site

Atlanta, Georgia 30342

0 studies enrolling now · 8 studies all time

What they study most

Acquired Thrombotic Thrombocytopenic Purpura, Clostridioides Difficile Infection, Clostridium Difficile Infection, Insomnia Disorder, Lupus Erythematosus, Systemic, Mycosis Fungoides, Ulcerative Colitis

Studies at this site

• ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection — Completed
• ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection — Completed
• Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura — Completed
• Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) — Completed
• A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis — Stopped early
• Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder — Completed
• Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma — Completed
• A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus — Completed